BerGenBio ASA

BATS-CHIXE:BGBIOO Stock Report

Market Cap: NOK 371.6m

BerGenBio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Martin Olin

Chief executive officer

NOK 10.2m

Total compensation

CEO salary percentage51.5%
CEO tenure3yrs
CEO ownership0.08%
Management average tenure2.9yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Martin Olin's remuneration changed compared to BerGenBio's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-NOK 155m

Mar 31 2024n/an/a

-NOK 155m

Dec 31 2023NOK 10mNOK 5m

-NOK 190m

Sep 30 2023n/an/a

-NOK 226m

Jun 30 2023n/an/a

-NOK 258m

Mar 31 2023n/an/a

-NOK 293m

Dec 31 2022NOK 11mNOK 5m

-NOK 302m

Sep 30 2022n/an/a

-NOK 294m

Jun 30 2022n/an/a

-NOK 304m

Mar 31 2022n/an/a

-NOK 309m

Dec 31 2021NOK 4mNOK 1m

-NOK 309m

Compensation vs Market: Martin's total compensation ($USD954.49K) is above average for companies of similar size in the UK market ($USD363.79K).

Compensation vs Earnings: Martin's compensation has been consistent with company performance over the past year.

CEO

Martin Olin (55 yo)

3yrs

Tenure

NOK 10,231,670

Compensation

Mr. Martin Olin serves as Chief Executive Officer at BerGenBio ASA since September 8, 2021. Mr. Olin has been Chairman of the Board at AcouSort AB (publ) since April 28, 2021. He has experience from execut...

Leadership Team

NamePositionTenureCompensationOwnership
Martin Olin
Chief Executive Officer3yrsNOK 10.23m0.078%
NOK 288.7k
Rune Skeie
Chief Financial Officer6.5yrsNOK 3.59m0.010%
NOK 37.0k
Cristina Oliva
Chief Medical Officer2.4yrsNOK 5.70mno data
Graham Morell
Head of IRno datano datano data
Gayle Mills
Chief Business Officer2.8yrsNOK 3.39mno data
Akil Jackson
Medical Directorno datano datano data

2.9yrs

Average Tenure

55yo

Average Age

Experienced Management: BGBIOO's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sally Bennett
Independent Non-Executive Director3.8yrsNOK 358.00k0.012%
NOK 44.9k
John Heymach
Member of Scientific Advisory Board1.6yrsno datano data
Shu Kam Mok
Member of Scientific Advisory Board1.6yrsno datano data
Debra Barker
Independent Non-Executive Director5.5yrsNOK 344.00k0.012%
NOK 44.3k
Anders Tullgren
Independent Chairman of the Board2.7yrsNOK 848.00k0.055%
NOK 205.8k
Enriqueta Font
Member of Scientific Advisory Board1.6yrsno datano data
Solange Peters
Member Scientific Advisory Board1.6yrsno datano data

1.6yrs

Average Tenure

61yo

Average Age

Experienced Board: BGBIOO's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/08 19:27
End of Day Share Price 2024/06/11 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BerGenBio ASA is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ulrik TrattnerCarnegie Investment Bank AB
Patrik LingDNB Markets
Geir HolomDNB Markets